| Cash flow (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Net income | 1.77B | 4.61B | 8.34B | 4.31B | 8.00B | 7.18B |
| Depreciation and amortization | 4.61B | 4.60B | 4.37B | 4.22B | 4.49B | 4.44B |
| Stock-based compensation | 535.00M | 540.00M | 588.00M | 447.00M | 484.00M | 400.00M |
| Cash from operations | 10.64B | 9.11B | 13.43B | 16.18B | 18.27B | 15.87B |
| Capital expenditure | -2.83B | -2.78B | -3.03B | -2.73B | -2.52B | -2.44B |
| Free cash flow | 7.81B | 6.33B | 10.39B | 13.45B | 15.74B | 13.43B |
| Acquisitions | -436.00M | -95.00M | -16.61B | -139.00M | -146.00M | -866.00M |
| Cash from investing | -5.87B | -7.61B | -20.89B | -5.05B | -5.26B | -5.53B |
| Dividends paid | -3.40B | -3.37B | -3.13B | -2.91B | -2.63B | -2.62B |
| Share buybacks | 0 | -3.02B | -2.01B | -3.50B | 0 | 0 |
| Net debt issued | 340.00M | 3.14B | 7.73B | -4.21B | -9.27B | -5.67B |
| Cash from financing | -4.94B | -1.14B | 2.68B | -10.52B | -11.36B | -7.70B |
| Net change in cash | -172.00M | 359.00M | -4.78B | 614.00M | 1.65B | 2.63B |
From CVS Health's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.